CAH

Cardinal Health
D

CAH

Arincen75/100B

Cardinal Health stock buybacks 1990–2027

Cardinal Health spent 500.00M USD buying back its shares in Q1 FY2027, the three months to 30 September 2026, up 33.3% on the same quarter a year before. Cardinal Health spent 1.36B USD buying back its shares in fiscal year 2026, up 77.5% on the year before.

Last updated 7 Nov 2026 · Next report 4 Feb 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 20261.48B—488.00M4.90B
FY202630 Jun 20261.36B+77.52%491.00M4.53B
FY202530 Jun 2025765.00M+2.00%494.00M1.85B
FY202430 Jun 2024750.00M-62.50%499.00M3.25B
FY202330 Jun 20232.00B+100.00%525.00M2.36B
FY202230 Jun 20221.00B+400.00%559.00M2.74B
FY202130 Jun 2021200.00M-42.86%573.00M2.03B
FY202030 Jun 2020350.00M-41.67%569.00M1.59B
FY201930 Jun 2019600.00M+9.09%577.00M2.39B
FY201830 Jun 2018550.00M-8.33%581.00M2.38B
FY201730 Jun 2017600.00M-7.83%577.00M797.00M
FY201630 Jun 2016651.00M-37.16%512.00M2.51B
FY201530 Jun 20151.04B+53.94%460.00M2.24B
FY201430 Jun 2014673.00M+49.56%415.00M2.28B
FY201330 Jun 2013450.00M0.00%353.00M1.53B
FY201230 Jun 2012450.00M+66.67%300.00M913.00M
FY201130 Jun 2011270.00M+17.39%274.20M1.10B
FY201030 Jun 2010230.00M—253.10M1.88B
FY200930 Jun 20090.00-100.00%200.40M1.03B
FY200830 Jun 20081.18B-67.73%173.10M1.14B
FY200730 Jun 20073.66B+144.15%144.40M865.70M
FY200630 Jun 20061.50B+199.80%101.80M1.70B
FY200530 Jun 2005500.30M-66.65%51.70M2.28B
FY200430 Jun 20041.50B+25.87%52.30M2.21B
FY200330 Jun 20031.19B+286.54%44.80M974.80M
FY200230 Jun 2002308.30M+121.16%45.00M698.50M
FY200130 Jun 2001139.40M-59.17%36.60M530.50M
FY200030 Jun 2000341.40M+614.23%30.00M330.40M
FY199930 Jun 199947.80M-69.16%56.70M-121.70M
FY199830 Jun 1998155.00M+311.14%11.50M28.40M
FY199730 Jun 199737.70M+1,994.44%9.10M-36.00M
FY199630 Jun 19961.80M-71.43%7.60M49.10M
FY199530 Jun 19956.30M-69.57%4.90M-32.50M
FY199430 Jun 199420.70M+2,857.14%4.00M-86.20M
FY199330 Jun 1993700.00K+250.00%1.60M101.20M
FY199230 Jun 1992200.00K—1.40M-102.70M
FY199130 Jun 19910.00-100.00%1.00M-34.30M
FY199030 Jun 19901.00M—0.0013.90M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Cardinal Health's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.